Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge
- PMID: 36507937
- PMCID: PMC9743123
- DOI: 10.1007/s11011-022-01134-x
Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge
Abstract
Hepatic Encephalopathy (HE) is a critically important complication of chronic liver disease and portal hypertension, but especially in early covert stages remains underdiagnosed and a common cause of hospitalization and morbidity. Defined by often subtle neuropsychiatric changes, significant cognitive deficits have been extensively described. While traditional methods of assessment remain underutilized in practice and subject to significant confounding with other diseases, mobile technology has emerged as a potential future tool to provide simple and dynamic cognitive assessments. This review discusses the proliferation of cognitive assessment tools, describing possible applications in encephalopathy and the challenges such an implementation may face. There are significant potential advantages to assessing cognition in real time in order to aid early detection and intervention and provide a more realistic measurement of real-world function. Despite this, there are issues with reliability, privacy, applicability and more which must be addressed prior to wide proliferation and acceptance for clinical use. Regardless, the rapid uptake of mobile technology in healthcare is likely to have significant implications for the future management of encephalopathy and liver disease at large.
Keywords: Cognition; Encephalopathy; Liver disease; Mobile technology; Portal hypertension; Remote monitoring.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures



Similar articles
-
Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis.J Hepatol. 2013 Sep;59(3):467-73. doi: 10.1016/j.jhep.2013.04.023. Epub 2013 May 7. J Hepatol. 2013. PMID: 23665182 Free PMC article.
-
Challenges in diagnosing hepatic encephalopathy.Neurochem Res. 2015 Feb;40(2):265-73. doi: 10.1007/s11064-014-1416-x. Epub 2014 Aug 21. Neurochem Res. 2015. PMID: 25142937 Review.
-
Review article: potential mechanisms of action of rifaximin in the management of hepatic encephalopathy and other complications of cirrhosis.Aliment Pharmacol Ther. 2016 Jan;43 Suppl 1:11-26. doi: 10.1111/apt.13435. Aliment Pharmacol Ther. 2016. PMID: 26618922 Review.
-
The portal hypertension syndrome: etiology, classification, relevance, and animal models.Hepatol Int. 2018 Feb;12(Suppl 1):1-10. doi: 10.1007/s12072-017-9827-9. Epub 2017 Oct 24. Hepatol Int. 2018. PMID: 29064029 Review.
-
Hepatic encephalopathy: a dynamic or static condition.Metab Brain Dis. 2005 Sep;20(3):193-204. doi: 10.1007/s11011-005-7207-x. Metab Brain Dis. 2005. PMID: 16167197 Review.
Cited by
-
The Importance of Making an Accurate Diagnosis for Hepatic Encephalopathy.Gastroenterol Hepatol (N Y). 2023 Dec;19(12):740-748. Gastroenterol Hepatol (N Y). 2023. PMID: 38404417 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical